002286.SZ
保龄宝
SZSE · Healthcare · C 制造业 · CN
CNY 7.77
−1.40%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.8B | 2.8B | 2.4B | 2.5B | 2.7B |
| Cost of Revenue | 2.4B | 2.4B | 2.1B | 2.3B | 2.4B |
| Gross Profit | 386.8M | 364.7M | 285.4M | 204.5M | 312.8M |
| Operating Expenses | |||||
| R&D Expense | 20.8M | 13.8M | 9.5M | 11.3M | 8.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 129.4M | 114.7M | 66.5M | 70.7M | 93.0M |
| Selling & Marketing Expense | 39.3M | 41.7M | 39.6M | 35.8M | 36.8M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 221.3M | 195.4M | 135.5M | 150.8M | 165.5M |
| Cost and Expenses | 2.6B | 2.6B | 2.3B | 2.5B | 2.6B |
| Operating Income (EBIT) | 183.0M | 178.5M | 154.0M | 64.0M | 160.2M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 182.9M | 177.8M | 131.1M | 65.1M | 156.7M |
| Income Tax Expense | 28.5M | 27.2M | 20.0M | 11.1M | 23.5M |
| Bottom Line | |||||
| Net Income | 154.4M | 150.6M | 111.2M | 54.0M | 133.2M |
| Earnings from Cont. Ops | 154.4M | 150.6M | 111.2M | 54.0M | 133.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 154.4M | 150.6M | 111.2M | 54.0M | 133.2M |
| Per Share | |||||
| Basic EPS | CN¥0.41 | CN¥0.41 | CN¥0.30 | CN¥0.15 | CN¥0.36 |
| Diluted EPS | CN¥0.41 | CN¥0.41 | CN¥0.30 | CN¥0.15 | CN¥0.36 |
| Revenue Per Share | CN¥7.28 | CN¥7.49 | CN¥6.48 | CN¥7.01 | CN¥7.33 |
| Shares | |||||
| Basic Shares Outstanding | 386.7M | 367.4M | 370.5M | 359.8M | 369.9M |
| Diluted Shares Outstanding | 386.7M | 367.4M | 370.5M | 359.8M | 369.9M |
| Profitability Metrics | |||||
| EBITDA | — | 308.7M | 283.4M | 189.9M | 265.8M |
| D&A | — | 130.2M | 129.4M | 125.9M | 105.6M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026